Assessment of Structural Intolerance and Durability
General Structure Information 2npp PPP2R1A structure of the protein phosphatase 2a holoenzyme 3.3Å AUTH Y.XU,Y.XING,Y.CHEN,Y.CHAO,Z.LIN,E.FAN,J.W.YU,S.STRACK,AUTH 2 P.D.JEFFREY,Y.SHITITL STRUCTURE OF THE PROTEIN PHOSPHATASE 2A HOLOENZYMEREF CELL(CAMBRIDGE,MASS.) V. 127 1239 2006REFN ISSN 0092-8674PMID 17174897DOI 10.1016/J.CELL.2006.11.033 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants
General Structure Information 2q4g RNH1 ensemble refinement of the protein crystal structure of human ribonuclease inhibitor complexed with ribonuclease i 1.95Å AUTH R.J.JOHNSON,J.G.MCCOY,C.A.BINGMAN,G.N.PHILLIPS JR.,AUTH 2 R.T.RAINESTITL INHIBITION OF HUMAN PANCREATIC RIBONUCLEASE BY THE HUMANTITL 2 RIBONUCLEASE INHIBITOR PROTEIN.REF J.MOL.BIOL. V. 368 434 2007REFN ISSN 0022-2836PMID 17350650DOI 10.1016/J.JMB.2007.02.005 Variant Set Distributions Mapped Variants
General Structure Information 1dx5 THBD crystal structure of the thrombin-thrombomodulin complex 2.3Å AUTH P.FUENTES-PRIOR,Y.IWANAGA,R.HUBER,R.PAGILA,G.RUMENNIK,AUTH 2 M.SETO,J.MORSER,D.R.LIGHT,W.BODETITL STRUCTURAL BASIS FOR THE ANTICOAGULANT ACTIVITY OF THETITL 2 THROMBIN-THROMBOMODULIN COMPLEXREF NATURE V. 404 518 2000REFN ISSN 0028-0836PMID 10761923DOI 10.1038/35006683 Variant Set Distributions Mapped Variants
General Structure Information 3th4 F7 mg2+ is required for optimal folding of the gamma-carboxyglutamic acid (gla) domains of vitamin k-dependent clotting factors at physiological ca2+ 1.8Å AUTH K.VADIVEL,S.AGAH,A.MESSER,D.CASCIO,S.M.BAJAJ,S.KRISHNASWAMY,AUTH 2 C.T.ESMON,K.PADMANABHAN,S.P.BAJAJTITL MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THETITL 2 GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMINTITL 3 K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+REF TO BE PUBLISHEDREFN […]
General Structure Information 3f6u PROC crystal structure of human activated protein c (apc) complexed with ppack 2.8Å AUTH A.E.SCHMIDT,K.PADMANABHAN,M.C.UNDERWOOD,W.BODE,T.MATHER,AUTH 2 S.P.BAJAJTITL THERMODYNAMIC LINKAGE BETWEEN THE S1 SITE, THE NA+ SITE, ANDTITL 2 THE CA2+ SITE IN THE PROTEASE DOMAIN OF HUMAN ACTIVATEDTITL 3 PROTEIN C (APC).REF J.BIOL.CHEM. V. 277 28987 2002REFN ISSN 0021-9258PMID 12029084DOI 10.1074/JBC.M201892200 […]
General Structure Information 4gj7 REN crystal structure of renin in complex with nvp-bca079 (compound 12a) 2.8Å AUTH E.LORTHIOIS,W.BREITENSTEIN,F.CUMIN,C.EHRHARDT,E.FRANCOTTE,AUTH 2 E.JACOBY,N.OSTERMANN,H.SELLNER,T.KOSAKA,R.L.WEBB,D.F.RIGEL,AUTH 3 U.HASSIEPEN,P.RICHERT,T.WAGNER,J.MAIBAUMTITL THE DISCOVERY OF NOVEL POTENT TRANS-3,4-DISUBSTITUTEDTITL 2 PYRROLIDINE INHIBITORS OF THE HUMAN ASPARTIC PROTEASE RENINTITL 3 FROM IN SILICO THREE-DIMENSIONAL (3D) PHARMACOPHORETITL 4 SEARCHES.REF J.MED.CHEM. V. 56 2207 2013REFN ISSN 0022-2623PMID 23425156DOI 10.1021/JM3017078 […]
General Structure Information 1jvq SERPINC1 crystal structure at 2.6a of the ternary complex between antithrombin, a p14-p8 reactive loop peptide, and an exogenous tetrapeptide 2.6Å AUTH A.ZHOU,P.E.STEIN,J.A.HUNTINGTON,P.SIVASOTHY,D.A.LOMAS,AUTH 2 R.W.CARRELLTITL HOW SMALL PEPTIDES BLOCK AND REVERSE SERPIN POLYMERISATIONREF J.MOL.BIOL. V. 342 931 2004REFN ISSN 0022-2836PMID 15342247DOI 10.1016/J.JMB.2004.07.078 Variant Set Distributions Ripley’s K Analysis Plots Variant Set […]
General Structure Information 4jnl PLAU crystal structure of upa in complex with its inhibitor 4- bromobenzylamine at ph 7.4 2.0Å AUTH X.ZHANG,L.JIANG,B.ZHAO,C.YUAN,M.HUANGTITL HALOGEN BONDS IN THE DESIGN OF SERINE PROTEASE INHIBITORSREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 3uo9 GLS crystal structure of human gac in complex with glutamate and bptes 2.3Å AUTH B.DELABARRE,S.GROSS,C.FANG,Y.GAO,A.JHA,F.JIANG,J.SONG J,AUTH 2 W.WEI,J.B.HUROVTITL FULL-LENGTH HUMAN GLUTAMINASE IN COMPLEX WITH AN ALLOSTERICTITL 2 INHIBITOR.REF BIOCHEMISTRY V. 50 10764 2011REFN ISSN 0006-2960PMID 22049910DOI 10.1021/BI201613D Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped […]
General Structure Information 4e90 PDE9A human phosphodiesterase 9 in complex with inhibitors 2.5Å AUTH M.M.CLAFFEY,C.J.HELAL,P.R.VERHOEST,Z.KANG,K.S.FORS,S.JUNG,AUTH 2 J.ZHONG,M.W.BUNDESMANN,X.HOU,S.LUI,R.J.KLEIMAN,AUTH 3 M.VANASE-FRAWLEY,A.W.SCHMIDT,F.MENNITI,C.J.SCHMIDT,AUTH 4 W.E.HOFFMAN,M.HAJOS,L.MCDOWELL,R.E.OCONNOR,AUTH 5 M.MACDOUGALL-MURPHY,K.R.FONSECA,S.L.BECKER,F.R.NELSON,AUTH 6 S.LIRASTITL APPLICATION OF STRUCTURE-BASED DRUG DESIGN AND PARALLELTITL 2 CHEMISTRY TO IDENTIFY SELECTIVE, BRAIN PENETRANT, IN VIVOTITL 3 ACTIVE PHOSPHODIESTERASE 9A INHIBITORS.REF J.MED.CHEM. V. 55 9055 2012REFN ISSN 0022-2623PMID 23025719DOI 10.1021/JM3009635 […]